These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3389056)

  • 1. Impaired fibrin formation in a patient with multiple myeloma presenting the "gelation" phenomenon.
    Ideguchi H; Suehiro T; Ohike M; Ohishi H; Katsuno M; Nishimura J; Ibayashi H
    Nihon Ketsueki Gakkai Zasshi; 1988 Feb; 51(1):109-17. PubMed ID: 3389056
    [No Abstract]   [Full Text] [Related]  

  • 2. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME; Zekert SL
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J; Soria C; Samama M; Fine JM; Bousser J
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Bothrops jararaca venom on fibrin formation in vitro.
    Ponari O; Civardi E
    Arzneimittelforschung; 1973 Jan; 23(1):94-8. PubMed ID: 4740702
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma.
    Lackner H; Hunt V; Zucker MB; Pearson J
    Br J Haematol; 1970 Jun; 18(6):625-36. PubMed ID: 5428623
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of some coagulation parameters in patients with neoplasms].
    Armani U; Piana A; Ponte M; Mandorla P; Longo A; Turco S
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2208-14. PubMed ID: 754715
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on fibrin formation and effects of dextran.
    Muzaffar TZ; Youngson GG; Bryce WA; Dhall DP
    Thromb Diath Haemorrh; 1972 Oct; 28(2):244-56. PubMed ID: 4639658
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ; Dray L; Ardaillou N
    Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
    O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
    J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal IgA serum protein having a poor precipitation reaction to anti-lambda chain antiserum in the patient with multiple myeloma].
    Sato K; Michibayashi T
    Rinsho Byori; 1985 Dec; 33(12):1425-9. PubMed ID: 3938490
    [No Abstract]   [Full Text] [Related]  

  • 15. Interference with fibrin formation in multiple myeloma by an unusual protein found in blood and urine.
    CRADDOCK CG; ADAMS WS; FIGUEROA WG
    J Lab Clin Med; 1953 Dec; 42(6):847-59. PubMed ID: 13109346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of fibrin peptides A and B on blood clot retraction].
    Borisova TA; Edokova GI
    Biull Eksp Biol Med; 1974 Aug; 78(8):45-8. PubMed ID: 4433758
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple myeloma. General etiologic data (68 cases). Blood and/or urine protein anomalies (67 cases)].
    Ben Abdeladhim A; Aissaoui B; Ben Othman T; Gharbi A; Bouguerra A; Boussen M
    Tunis Med; 1989 Oct; 67(10):607-12. PubMed ID: 2683278
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid gel reaction of serum and pyroglobulins in 5 cases of multiple myelomas and a case of macroglobulinemia.
    Viranuvatti V; Thongsomboon Y
    J Med Assoc Thai; 1971 Jan; 54(1):47-61. PubMed ID: 4993517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of cytomegalovirus infection on the mechanism of coagulation].
    Li N
    Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):675-6. PubMed ID: 2835130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.